期刊
AMERICAN JOURNAL OF INFECTION CONTROL
卷 46, 期 6, 页码 602-609出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ajic.2018.01.018
关键词
Surgical infection risk factor modification; Surgical prophylaxis; Skin antisepsis; Normothermia; Oxygenation; Glycemic control
资金
- Johnson & Johnson Medical Devices Companies, an APIC
Surgical site infections remain a common cause of morbidity, mortality, and increased length of stay and cost amongst hospitalized patients in the United States. This article summarizes the evidence used to inform the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Guideline for the Prevention of Surgical Site Infection (2017), and highlights key updates and new recommendations. We also present specific suggestions for how infection preventionists can play a central role in guideline implementation by translating these recommendations into evidence-based policies and practices in their facility. (c) 2018 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据